Page last updated: 2024-11-01

norfloxacin and Candidiasis, Vulvovaginal

norfloxacin has been researched along with Candidiasis, Vulvovaginal in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Candidiasis, Vulvovaginal: Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rocha, RM1
Zanni, PC1
de Souza Bonfim-Mendonça, P1
Gimenes, F1
Alczuk, SS1
Svidzinski, TI1
Consolaro, ME1
Menday, AP1

Trials

1 trial available for norfloxacin and Candidiasis, Vulvovaginal

ArticleYear
Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:4

    Topics: Adult; Amdinocillin Pivoxil; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Middle

2002

Other Studies

1 other study available for norfloxacin and Candidiasis, Vulvovaginal

ArticleYear
Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.
    International urogynecology journal, 2016, Volume: 27, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Brazil; Candida; Candidiasis, Vulvovaginal;

2016